Alkem Laboratories together with its subsidiary M/s. Enzene Biosciences (Enzene) has entered into a Share Subscription and Shareholders’ agreement on December 17, 2024 with M/s. Sunsure Solarpark Twenty Two (Sunsure Solarpark) and M/s. Sunsure Energy for equity investment in Sunsure Solarpark. The said investment will be completed by the end of April, 2025.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.